Stephanie C. Read
Director/Board Member bei ALSP ORCHID ACQUISITION CORPORATION I
Profil
Stephanie C.
Read is currently the President, Chief Executive Officer & Director at Ironshore Therapeutics, Inc. She is also an Independent Director at ALSP Orchid Acquisition Corp.
I.
Previously, she held the position of Vice President-Strategy & Development at CSL Ltd.
(United States) and was a Member-Maryland Chapter at Project 1972, Inc. Stephanie's former job was as an Executive Director-Corporate Strategy & Ventures at AstraZeneca PLC from 2013 to 2015.
She holds a graduate degree from The Johns Hopkins University and an undergraduate degree from Virginia Polytechnic Institute & State University.
Aktive Positionen von Stephanie C. Read
| Unternehmen | Position | Beginn |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Director/Board Member | - |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Chief Executive Officer | 28.04.2022 |
| CSL Ltd. (United States) | Corporate Officer/Principal | 01.01.2015 |
Project 1972, Inc.
 Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Project 1972, Inc. engages in the provision of private networking platform for women. Its membership services include core group, salon series, connection, and clubhouses access. The company was founded by Lindsay Kaplan and Carolyn Childers in 2017 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Stephanie C. Read
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.07.2015 |
Ausbildung von Stephanie C. Read
| The Johns Hopkins University | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Ironshore Therapeutics, Inc.
Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ironshore Therapeutics, Inc. operates as a pharmaceutical company. The firm offers HLD-200, HLD-900, the morning routine and the delexis products. It develops commercialization of a proprietary drug delivery system. The company was founded by David Gordon MacLeod Lickrish in 2008 and is headquartered in Toronto, Canada. | Health Technology |
| CSL Ltd. (United States) | |
Project 1972, Inc.
Project 1972, Inc. Miscellaneous Commercial ServicesCommercial Services Project 1972, Inc. engages in the provision of private networking platform for women. Its membership services include core group, salon series, connection, and clubhouses access. The company was founded by Lindsay Kaplan and Carolyn Childers in 2017 and is headquartered in New York, NY. | Commercial Services |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA. | Finance |
